Autosomal recessive axonal Charcot-Marie-Tooth type 2S (CMT2S) is a rare inherited nerve disease. It mainly damages the long nerves in the arms and legs (peripheral nerves), especially the “axon,” which is the central wire of the nerve fiber. Because of this axon damage, the signals from the brain to the muscles become weak and slow. Over time, this causes slowly progressive weakness and wasting of the small muscles of the feet, legs, hands, and forearms, with reduced or absent reflexes and some loss of feeling. Symptoms often start in childhood, usually in the first decade of life, but can appear later in some people.NCBI+2malacards.org+2
Autosomal recessive axonal Charcot-Marie-Tooth type 2S (CMT2S) is a very rare inherited nerve disease. It mainly damages the long “wires” of the peripheral nerves, called axons. These nerves carry messages from the brain and spinal cord to the muscles and from the skin back to the brain. In CMT2S, these axons slowly stop working properly, so muscles in the feet, legs, hands and arms become weak and thin, and feeling (sensation) is reduced. Symptoms usually start in childhood, often in the first decade of life. Children may trip often, have foot deformities like high arches, and later find fine hand tasks difficult.NCBI+1
CMT2S is “autosomal recessive,” which means a person becomes ill only if they inherit two faulty copies of a gene, one from each parent. Parents are usually healthy “carriers.” Most cases of CMT2S are linked to harmful changes (mutations) in a gene called IGHMBP2. This gene helps nerve cells survive and handle their normal work. When IGHMBP2 does not work correctly, motor and sensory nerves slowly degenerate, leading to weakness, wasting of distal muscles, loss of ankle reflexes and variable sensory loss.PMC+2National Organization for Rare Disorders+2
In CMT2S, the problem comes from harmful changes (mutations) in a gene called IGHMBP2 on chromosome 11. This gene gives instructions to make a protein that helps motor nerves survive and handle DNA and RNA. When this gene does not work properly, motor and sensory nerves in the limbs slowly degenerate. CMT2S is called “autosomal recessive” because a child becomes affected only when they receive one faulty copy of IGHMBP2 from each parent.search.thegencc.org+3Frontiers+3Europe PMC+3
CMT2S is considered a “pure” axonal hereditary motor and sensory neuropathy. That means most problems come from damage to motor and sensory fibers without major problems in other organs. Many patients keep normal breathing function, which helps to distinguish CMT2S from a related IGHMBP2 condition called spinal muscular atrophy with respiratory distress type 1 (SMARD1), which has severe breathing problems in infancy.malacards.org+2PubMed+2
Other names
This disease appears in the medical literature under several names. Knowing these names is helpful when you read articles or reports:
Charcot-Marie-Tooth disease axonal type 2S – this is a very common formal name used in genetic and neurology databases.NCBI+1
Charcot-Marie-Tooth disease type 2S (CMT2S) – this shorter name is often used in clinical papers and patient information sites.Mouse Genome Informatics+1
Autosomal recessive axonal Charcot-Marie-Tooth type 2S – this name stresses the inheritance pattern (autosomal recessive) and the axonal nature of the neuropathy.Mouse Genome Informatics+1
Charcot-Marie-Tooth neuropathy type 2S – this wording focuses on the neuropathy (nerve disease) aspect but refers to the same condition.NCBI+2diseases.jensenlab.org+2
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2S – this longer label is often used in OMIM and genetic testing catalogues.cosylab.iiitd.edu.in+1
All of these terms point to the same disease: a rare, IGHMBP2-related, autosomal recessive axonal Charcot-Marie-Tooth neuropathy.diseases.jensenlab.org+1
Types or clinical patterns of CMT2S
Doctors do not officially divide CMT2S into rigid “types” like type A, B, or C. However, case reports and research on people with IGHMBP2 mutations show some clinical patterns that can help describe the disease course:Nature+3Frontiers+3Europe PMC+3
Classic childhood-onset CMT2S
In this common pattern, symptoms start in the first decade of life. Children develop weakness in the feet and lower legs, have trouble running, and show slowly progressive muscle wasting in the calves and later in the hands. Sensory loss and reduced reflexes are present but not the main complaint.NCBI+1Severe early-onset CMT2S
Some patients present very early with marked weakness and may have delayed walking or unstable gait. They may show more rapid progression and noticeable disability in adolescence. This pattern reminds clinicians that IGHMBP2 mutations can sometimes cause a more severe spectrum overlapping with other motor neuron disorders.Frontiers+1Late-onset CMT2S
A few reports describe people who develop CMT2S symptoms later, even in adulthood, with milder weakness and slower progression. In these cases, diagnosis can be delayed, and genetic testing is often needed because standard nerve studies just show an axonal neuropathy.PubMed+1Motor-predominant CMT2S
In some patients, weakness and wasting of distal muscles are much more obvious than sensory loss. They may complain more about foot drop, tripping, and hand weakness while sensory symptoms (numbness, tingling) are subtle.malacards.org+1Sensory-motor mixed CMT2S
Other patients show clear loss of vibration, position sense, or pain sensation along with weakness. They may have more balance problems and sensory ataxia. This shows that both motor and sensory axons can be involved to different degrees in the same disease.malacards.org+2PMC+2
Causes
Before listing many “causes,” it is very important to say clearly:
There is only one direct basic cause of CMT2S – disease-causing mutations in the IGHMBP2 gene.
The items below describe different aspects of this genetic cause, the ways mutations can appear, and risk factors that make them more likely.diseases.jensenlab.org+2search.thegencc.org+2
Pathogenic IGHMBP2 gene mutation
The main cause is a harmful change (pathogenic variant) in both copies of the IGHMBP2 gene. This change stops the gene from making a fully normal protein. The defective protein cannot support healthy survival and function of motor and sensory neurons, so their axons gradually degenerate.Europe PMC+2Frontiers+2Homozygous IGHMBP2 variants
Many patients have the same mutation on both gene copies (homozygous). This usually happens when both parents carry the same silent mutation. Receiving this mutation twice gives the child no working copy of IGHMBP2 in motor neurons, leading to CMT2S.Europe PMC+1Compound heterozygous IGHMBP2 variants
Some patients inherit two different harmful mutations in IGHMBP2, one from each parent. This is called compound heterozygosity. Even though the mutations differ, together they reduce protein function enough to cause axonal neuropathy.NMD Journal+1Missense mutations in functional domains
Missense variants change one amino acid in the protein and can disturb important domains, such as helicase and ATP-binding regions. Studies show that many CMT2S cases have missense mutations that partially reduce IGHMBP2 activity in neurons.Europe PMC+1Truncating mutations (nonsense or frameshift)
Nonsense or frameshift mutations can create a shortened, unstable protein that is quickly destroyed in the cell. This leads to very low levels of functional IGHMBP2 and can cause more severe neuropathy.Europe PMC+1Splice-site mutations
Some variants appear near splice sites of the gene and interfere with normal processing of RNA. Abnormal splicing can remove or insert exons, producing a faulty protein that cannot support axon health.Europe PMC+1Mutations in conserved helicase motifs
IGHMBP2 has conserved helicase motifs that bind and unwind nucleic acids. Mutations in these key motifs are especially damaging because they directly affect the core biochemical function of the protein, weakening motor neurons over time.Frontiers+1Mutations affecting protein stability or location
Some variants may not change the active site but alter protein folding or where it is located inside the cell. Unstable or mis-placed IGHMBP2 cannot do its job in motor neurons, leading to chronic axonal degeneration.Frontiers+1Autosomal recessive inheritance from carrier parents
CMT2S appears when a child receives a faulty IGHMBP2 copy from each parent. Parents are usually healthy “carriers.” In each pregnancy, there is a 25% chance that the child will inherit both faulty copies and develop disease.GARD Information Center+1Parental consanguinity (blood-related parents)
When parents are related by blood, they are more likely to share the same rare mutation. This increases the chance that their children will inherit that mutation in both copies and develop an autosomal recessive disease such as CMT2S.search.thegencc.org+1Founder effect in small populations
In some families or small communities, the same IGHMBP2 mutation may be passed down through many generations. This “founder” variant can lead to multiple affected relatives, even though the disease is rare worldwide.ResearchGate+1Family history of IGHMBP2-related neuropathy
Having older brothers, sisters, or cousins diagnosed with CMT2S or IGHMBP2-linked disease shows that this disease-causing variant is present in the family gene pool, making it a strong cause for later affected children.Europe PMC+1IGHMBP2 variants with partial function
Not all mutations completely destroy protein function. Some allow a little activity, leading to milder forms like classic CMT2S rather than lethal SMARD1. The combination and location of these variants help determine whether the person develops CMT2S phenotype.Frontiers+1IGHMBP2 variants shared with SMARD1 spectrum
Research shows that some IGHMBP2 mutations can cause either SMARD1 or CMT2S, or a mixed picture, depending on how they change the protein. This shared genetic background explains why these diseases form a continuum.PubMed+1Modifier genes in axonal neuropathy
Other genes involved in axon structure and repair may modify how IGHMBP2 mutations present. While they do not cause CMT2S by themselves, their interaction can influence how early and how severe symptoms become.PMC+1Additional acquired stress on already weak axons
Conditions like uncontrolled diabetes, severe vitamin deficiencies, or long-standing alcohol misuse can further damage peripheral nerves. They do not cause CMT2S, but in a person with IGHMBP2 mutations they may worsen the neuropathy.PMC+1Use of neurotoxic medicines in CMT2S patients
Some chemotherapy drugs (for example vincristine) and certain other medications can be toxic to peripheral nerves. In someone with CMT, these drugs can make weakness and sensory loss worse, so they are usually avoided if possible.PMC+1Severe physical nerve injury in affected limbs
Trauma that stretches or compresses nerves can cause extra axonal damage. For a person whose axons are already fragile because of IGHMBP2 mutations, such trauma may produce a sudden step-down in strength or feeling.PMCLong-standing joint deformity and nerve compression
High arches, hammer toes, or ankle deformities may lead to abnormal pressure on nerves around the ankle or foot. Over many years this compression can further damage already weak nerve fibers in CMT2S.Wikipedia+1Delayed diagnosis and lack of supportive care
The gene mutation is present from birth, but if the disease is not recognized, the person may not receive physiotherapy, orthotics, or lifestyle advice. This does not cause CMT2S, but it allows preventable secondary damage, making weakness and deformity worse over time.PMC+1
Symptoms
Slowly progressive weakness in feet and lower legs
The earliest sign is often weakness around the ankles and feet. Children may run more slowly than peers, trip often, or have trouble climbing stairs. This weakness slowly worsens over years as the motor axons to these muscles degenerate.NCBI+2malacards.org+2Muscle wasting (atrophy) of calves and later hands
Over time, the small muscles in the lower legs shrink, giving the legs a “stork-like” or thin appearance. Later, the small muscles in the hands can also waste away, making the fingers look bony. This comes from long-standing loss of nerve supply.NCBI+2PMC+2Foot drop and tripping
Because the muscles that lift the foot are weak, the front of the foot may drag on the ground. This is called foot drop. Patients may lift their knees higher with each step to avoid dragging, which can make their walk look “steppage-like.”Wikipedia+1High-arched feet and toe deformities
Many people with CMT develop high arches (pes cavus) and clawed or hammer toes. These deformities form slowly as muscle balance around the foot changes. They can cause pain, calluses, and difficulty finding comfortable shoes.Wikipedia+2CMT Research Foundation+2Reduced or absent reflexes
Doctors often find reduced ankle and knee reflexes when they tap the tendons with a hammer. Reflex loss happens because the nerve circuits that normally cause the muscle to jerk are damaged by the axonal neuropathy.NCBI+1Numbness and reduced sensation in feet and hands
Sensory fibers are also affected, so people may feel numbness, “deadness,” or reduced sensitivity to touch and temperature in their feet, and later in their hands. They may not feel small injuries, which increases the risk of unnoticed skin damage.NCBI+2malacards.org+2Tingling, burning, or electric-like pain
Some patients report tingling, burning, or electric shocks in their feet or legs, especially at night. This “neuropathic pain” comes from irritated or mis-firing sensory axons. It can affect sleep and quality of life even when weakness is mild.PMC+1Poor balance and unsteady walking
Loss of position sense in the feet combined with weakness makes it hard to keep balance, especially in the dark or on uneven ground. People may sway when standing with their eyes closed or need support when walking on rough surfaces.PMC+1Difficulty with fine hand tasks
When the small muscles of the hands become weak, everyday tasks like buttoning clothes, writing, tying shoelaces, or opening small jars become harder. This is often noticed later in the disease course after leg symptoms.malacards.org+1Fatigue and reduced stamina
Because muscles are weak and nerves are damaged, people tire more easily, especially when walking long distances or standing for a long time. They may need frequent rests or assistive devices such as ankle-foot orthoses.PMC+1Muscle cramps and twitching
Some patients experience muscle cramps or visible twitches (fasciculations) in the legs or feet. These signs reflect unstable motor units and hyper-excitable nerves as the axons degenerate.PMC+1Mild scoliosis or skeletal changes
As muscle weakness and imbalance progress, the spine and joints may gradually adopt abnormal positions, leading to mild scoliosis or other skeletal alignment problems. These changes are more common in generalized CMT and may appear in CMT2S as well.Wikipedia+1Cold, discolored feet or hands
Poor nerve supply can also affect small blood vessels, so the feet and hands may feel unusually cold or look pale or bluish. This is usually mild but can add to discomfort.PMC+1Clumsiness in childhood
Parents may first notice that a child is clumsy, falls often, or has trouble keeping up during sports. These signs can be early clues to an underlying hereditary neuropathy like CMT2S rather than simple lack of coordination.NCBI+2MDPI+2Occasional respiratory or bulbar signs in some cases
Most people with CMT2S have normal breathing, but rare reports describe cases with some respiratory weakness or cough problems, especially in those at the severe end of the IGHMBP2 disease spectrum. These features are milder than in SMARD1 but remind clinicians to check breathing function.PubMed+2IJB Management+2
Diagnostic tests
Physical examination–based tests
Complete neurological examination
The neurologist looks at muscle bulk, strength, reflexes, sensation, and coordination in the arms and legs. In CMT2S, this exam usually shows distal muscle weakness and atrophy, reduced reflexes, and variable sensory loss, especially in the feet and hands.NCBI+2malacards.org+2Gait and posture assessment
The doctor watches how the patient walks, runs, and stands. A “steppage” gait with high knee lift, foot drop, and difficulty walking on heels or toes suggests a distal motor neuropathy like CMT2S. The doctor may also note foot deformities.Wikipedia+1Reflex testing with a tendon hammer
The examiner taps the knee and ankle tendons to check reflexes. In CMT2S and other axonal CMTs, ankle jerks are often reduced or absent, and knee jerks may also be weak. This supports the diagnosis of peripheral neuropathy.NCBI+2PMC+2Sensory examination
Light touch, pinprick, vibration, and joint position sense are tested at different levels on the feet and hands. A length-dependent pattern of sensory loss, starting in the toes and moving upward, is typical of axonal hereditary motor and sensory neuropathy.PMC+1Functional assessments (e.g., timed walk tests)
Simple timed tests, such as walking 10 meters or rising from a chair, can be used to follow changes in strength and balance over time. They do not confirm the diagnosis but help track progression and response to supportive therapies or future clinical trials.PMC+1
Manual tests
Manual muscle testing (MRC scale)
The clinician tests each major muscle group by hand and grades strength on a standard scale (Medical Research Council scale from 0 to 5). In CMT2S, distal muscles (foot and hand) are weaker than proximal muscles, and this pattern can be followed over time.PMC+1Heel–toe walking test
Patients are asked to walk on their heels and then on their toes. Difficulty lifting the front of the foot (heel walking) and weakness in toe walking suggest weakness of ankle dorsiflexors and plantar flexors, which is common in CMT2 forms.Wikipedia+1Romberg balance test
The patient stands with feet together, first with eyes open and then closed. Increased sway or near-fall when the eyes are closed indicates impaired position sense from large sensory fibers, which can be affected in axonal neuropathies like CMT2S.PMC+1Manual assessment of joints and foot deformities
The clinician gently moves the ankle, toes, and other joints to check range of motion, stiffness, and deformities such as high arches and claw toes. These findings support a chronic neuropathy and guide the need for orthotics or surgery.Radiopaedia+1
Laboratory and pathological tests
Basic blood tests to exclude other causes
Blood tests like complete blood count, blood sugar, kidney and liver function, vitamin B12, and thyroid levels are often done. They do not diagnose CMT2S directly but help rule out other treatable causes of neuropathy, such as diabetes or vitamin deficiency.PMC+1Creatine kinase (CK) level
CK is an enzyme released from damaged muscle. In pure neuropathies like CMT2S, CK is usually normal or only mildly raised. A normal or slightly raised CK helps support a neuropathic rather than a primary muscle disease.PMC+1Targeted genetic test for IGHMBP2
Once an inherited axonal neuropathy is suspected, a specific genetic test for IGHMBP2 can be ordered. Finding disease-causing variants in both gene copies confirms the diagnosis of CMT2S and allows family counseling and carrier testing.Europe PMC+2diseases.jensenlab.org+2Next-generation sequencing neuropathy panels
Many centers use broad gene panels that test dozens or hundreds of neuropathy genes at once. IGHMBP2 is included in these panels, and identifying mutations here can distinguish CMT2S from other CMT2 subtypes caused by genes like MFN2 or RAB7.PMC+2ScienceDirect+2Nerve biopsy and pathological study (selected cases)
In unclear cases, a small sensory nerve from the lower leg may be removed and studied under the microscope. In axonal CMT such as CMT2S, pathology shows primary loss of axons with relatively preserved myelin, helping to classify the neuropathy as axonal. Today, genetic testing usually replaces biopsy.PMC+2Wikipedia+2
Electrodiagnostic tests
Motor nerve conduction studies (NCS)
Electrodes stimulate a motor nerve and record the response in the muscle. In CMT2S, conduction velocity is often near normal or only slightly slowed, but the response amplitude is reduced, indicating loss of axons rather than demyelination.PMC+1Sensory nerve conduction studies
Similar tests are done on sensory nerves. Reduced amplitudes of sensory action potentials with relatively preserved conduction speed support an axonal sensory neuropathy, which fits with CMT2 classification.PMC+1Electromyography (EMG)
A thin needle electrode is inserted into muscles to record electrical activity. In CMT2S, EMG shows signs of chronic denervation and re-innervation, such as large, long-duration motor unit potentials, reflecting long-standing axonal loss.PMC+2MDPI+2
Imaging tests
MRI of peripheral nerves or plexus (MR neurography)
In some research or complex cases, MRI can image nerve roots and plexuses. It may show nerve enlargement or signal change, but in many CMT2S patients MRI is mainly used to exclude other causes of neuropathy rather than to confirm the diagnosis.Radiopaedia+1Spinal MRI to rule out other motor neuron diseases
Because IGHMBP2 mutations can also cause SMARD1 and other motor neuron problems, a spinal MRI may be done when symptoms suggest spinal cord or anterior horn cell disease. A normal spinal MRI with clear peripheral nerve involvement supports the diagnosis of CMT2S rather than central disease.Frontiers+1Foot and ankle X-rays
Simple X-rays can show high arches, claw toes, and other bone deformities that result from chronic muscle imbalance. These images do not diagnose CMT2S alone, but they help orthopedic surgeons plan braces or corrective surgery and document progression.Radiopaedia+1
Non-pharmacological treatments (therapies and others)
Below are key non-drug treatments. In real life, a specialist team designs a personalized plan.
Regular physical therapy (physiotherapy)
Physical therapy is one of the most important treatments for CMT2S. A physiotherapist uses stretching, low-impact strengthening, balance and gait exercises to keep joints moving and muscles as strong and flexible as possible. The main purpose is to delay contractures (shortening of muscles and tendons), maintain walking ability, and reduce pain and fatigue. The mechanisms are simple: regular movement improves blood flow, keeps muscles from stiffening, and trains the nervous system to use remaining nerve pathways more efficiently.NCBI+2nhs.uk+2Strength and endurance training
Gentle strength training with light weights or resistance bands and low-impact aerobic exercise (like cycling or swimming) can help preserve muscle mass and reduce tiredness. The purpose is not to build big muscles but to prevent further weakness and support everyday activities like walking and climbing stairs. The mechanism is that repeated, controlled muscle activity stimulates remaining motor units, improves mitochondrial function in muscle cells and helps the body use oxygen more efficiently, which can improve stamina.Physiopedia+1Stretching and contracture prevention
Daily stretching of ankles, calves, hamstrings, and fingers helps keep joints flexible. In CMT2S, weak muscles around the ankle and foot make it easy for tendons to tighten. The purpose of stretching is to maintain the full range of motion and delay fixed deformities, such as equinus (toe-walking) or claw toes. Stretching works by gently lengthening muscle fibers and connective tissue, reducing stiffness and promoting normal joint alignment over time.nhs.uk+1Orthotics and ankle-foot orthoses (AFOs)
Many people with CMT2S develop “foot drop,” where the front of the foot drags while walking. Custom ankle-foot orthoses and supportive shoes help lift the foot, stabilize the ankle and improve balance. The purpose is to prevent falls, reduce fatigue, and slow worsening of deformities. AFOs work by mechanically holding the ankle in a more neutral position so the person does not need to overuse hip and knee muscles to clear the toes during walking.Mayo Clinic+2Charcot-Marie-Tooth Association+2Occupational therapy (hand and daily living training)
Occupational therapists teach ways to make self-care, school, and work tasks easier, using adaptive tools like special grips, button hooks, and writing aids. The purpose is to maintain independence in dressing, eating, typing and other fine motor tasks. Mechanistically, occupational therapy focuses on energy conservation, task modification and compensating for weak hand muscles by changing how you perform an activity and what tools you use.NCBI+1Assistive devices for mobility
Canes, walkers, and wheelchairs can be introduced if balance is poor or falls are frequent. The purpose is safety and participation in daily life, not “giving up.” These devices work by increasing the number of contact points with the ground and widening the base of support, which reduces the chance of losing balance and lowers the energy cost of walking.Cleveland Clinic+1Foot care and podiatry
Regular visits to a podiatrist for nail trimming, callus removal and skin checks are important, especially if sensation is reduced. The goal is to prevent ulcers, infections and painful pressure points. The mechanism is simple: early care for minor skin problems and pressure distribution with proper footwear stops small issues from becoming serious wounds.ScienceDirect+1Balance and gait training
Special exercises using balance boards, standing drills and gait practice help the brain adapt to sensory loss. The purpose is to reduce falls and improve confidence while walking. By repeatedly challenging balance in a controlled setting, the nervous system learns to rely more on visual cues and remaining sensory input, strengthening alternative pathways for postural control.Charcot-Marie-Tooth Disease+1Respiratory assessment and therapy (in selected patients)
Some people with IGHMBP2-related disease can have breathing or respiratory muscle problems. A specialist may check lung function and recommend breathing exercises or non-invasive ventilation at night if needed. The purpose is to prevent low oxygen, fatigue and sleep problems. The mechanism is support of weakened respiratory muscles so breathing stays effective, especially during sleep when muscles relax.ijbm.org+1Pain psychology and cognitive-behavioural therapy (CBT)
Chronic neuropathic pain and disability can cause anxiety and low mood. Psychologists can teach relaxation, coping skills and CBT strategies to manage pain and stress. The purpose is to change how the brain processes pain signals and reduce the emotional suffering linked to pain. CBT works by identifying unhelpful thought patterns (“I can’t do anything”) and replacing them with more balanced thoughts and practical coping steps.NCBI+1Education and genetic counselling
Families with CMT2S benefit from clear explanations of inheritance, recurrence risk and options such as carrier testing. The aim is informed decision-making about future pregnancies and earlier diagnosis of affected relatives. The mechanism is not medical but informational: good counselling reduces fear, confusion and guilt, and helps families plan.Muscular Dystrophy Association+1Mental health support and peer groups
Living with a rare disease can feel isolating. Support groups, either online or in person, and mental health care help reduce depression and anxiety. The purpose is emotional resilience and social connection. Sharing experiences with others who have CMT can normalize feelings and provide practical tips that professionals may not think of.Cleveland Clinic+1Home and school adaptations
Simple changes, like grab bars in the bathroom, ramps, non-slip mats, or extra time for school tasks, reduce risk and stress. The aim is to fit the environment to the person’s abilities. Mechanistically, removing physical barriers and hazards lowers the probability of falls and allows energy to be saved for meaningful activities.ResearchGate+1Vocational and educational rehabilitation
As teens and young adults with CMT2S plan their future work or studies, vocational counsellors can suggest roles that fit their physical abilities and interests. The purpose is long-term independence and job satisfaction. This works by matching job demands to the person’s realistic strength, endurance and mobility, preventing burnout and injury.Dove Medical PressWeight management and healthy lifestyle coaching
Extra body weight makes walking, climbing stairs and transfers harder when muscles are weak. Dietitians can create a balanced diet plan that maintains a healthy weight. The mechanism is straightforward: less weight means less load on weak muscles and joints, improving mobility and reducing pain.NCBI+1Sleep hygiene strategies
Pain, leg cramps or breathing issues may disturb sleep. Good sleep habits (regular schedule, comfortable mattress, cool dark room, limiting screens) plus proper pain control can improve rest. The purpose is better daytime energy and mood. Sleep hygiene works by supporting the body’s natural sleep-wake cycle so repair processes in nerve and muscle tissue can work efficiently.NCBI+1Avoidance of neurotoxic medications and toxins
Some medicines (such as certain chemotherapy drugs) and toxins can worsen neuropathy. Doctors caring for someone with CMT2S carefully review drug lists to avoid these when possible. The aim is to prevent additional nerve damage on top of the genetic disease.NCBI+1Regular clinical follow-up
Even though extensive routine tests are not always needed, periodic neurological and orthopedic check-ups help track progression, adjust braces, and plan new therapies. The purpose is early detection of treatable complications like scoliosis, foot ulcers or significant breathing problems.ResearchGate+1Fall-prevention training
Teaching safe ways to turn, transfer, and move on stairs reduces falls. Therapists may also suggest hip protectors or padded shoes. The mechanism is a mix of training the body, improving the environment, and using protective equipment to lower injury risk when balance is impaired.Charcot-Marie-Tooth Disease+1Participation in clinical research and registries
Registries and research studies, including trials for CMT2S, help doctors learn more and may give access to experimental therapies in the future. The purpose is long-term progress for the whole CMT community, even though it may not offer immediate personal benefit.Charcot-Marie-Tooth Association+2ClinicalTrials.gov+2
Drug treatments (symptom-based medical management)
Important safety note: Only a qualified doctor or pediatric neurologist should choose medicines and doses. Never start, adjust, or stop prescription drugs without medical supervision.
Right now, there is no FDA-approved drug that cures autosomal recessive axonal CMT2S. Medicines are used to treat symptoms, mainly neuropathic pain, muscle spasms, mood problems, and sleep disturbances. Many of these drugs are approved for other nerve pain conditions, and their official prescribing information is available on accessdata.fda.gov.FDA Access Data+4NCBI+4Cleveland Clinic+4
Below are examples of commonly used classes; dosing must follow the official label and the treating doctor’s judgment.
Gabapentin
Gabapentin is an anticonvulsant widely used for neuropathic pain. It reduces abnormal nerve firing in pain pathways, which can lessen burning, tingling and electric-shock sensations. The purpose in CMT2S is to make chronic nerve pain more manageable and improve sleep and daily function. On the FDA label, gabapentin is approved for post-herpetic neuralgia and seizures; doctors may use similar dosing patterns and slowly adjust the dose based on response and side effects such as dizziness, sleepiness and swelling.FDA Access Data+2FDA Access Data+2Pregabalin
Pregabalin is another anticonvulsant used for several neuropathic pain conditions. It works by binding to calcium channels in nerve cells and reducing the release of excitatory neurotransmitters. The purpose is to reduce nerve pain and improve sleep quality. The FDA label describes its use in painful diabetic neuropathy, post-herpetic neuralgia and fibromyalgia, with side effects like dizziness, sleepiness, weight gain and peripheral edema. In CMT2S, doctors may consider similar pain-relief strategies but always individualize dosing.FDA Access Data+2FDA Access Data+2Duloxetine
Duloxetine is a serotonin–noradrenaline reuptake inhibitor (SNRI) antidepressant that is also approved for diabetic peripheral neuropathic pain. It boosts levels of these neurotransmitters in pain-modulating pathways in the spinal cord and brain, which can dampen pain signals. Its purpose in CMT-related neuropathic pain is dual: reduce chronic pain and help with low mood or anxiety. Common side effects from the label include nausea, dry mouth, sleepiness and reduced appetite, so doctors start at low doses and monitor carefully.FDA Access Data+2FDA Access Data+2Tricyclic antidepressants (e.g., amitriptyline, nortriptyline)
These older antidepressants are often used in low doses for nerve pain. They block reuptake of serotonin and noradrenaline and have additional actions on pain pathways. The purpose is to reduce nighttime neuropathic pain and improve sleep. Side effects can include dry mouth, constipation, drowsiness and sometimes heart rhythm changes, so they must be used cautiously, especially in young people or those with heart disease.NCBI+1Topical agents (lidocaine patches, capsaicin cream)
For localized painful areas, doctors may use lidocaine patches or capsaicin creams. These act directly on nerve endings in the skin, reducing firing of pain fibers without affecting the whole body. The purpose is targeted pain relief with fewer systemic side effects. Lidocaine works by blocking sodium channels in nerves, while capsaicin depletes substance P, a pain neurotransmitter, from nerve endings.NCBI+1Non-steroidal anti-inflammatory drugs (NSAIDs)
Medicines like ibuprofen or naproxen may help with musculoskeletal pain from overworked joints and muscles rather than nerve pain itself. The purpose is short-term relief of inflammatory pain after activity or surgery. These drugs block cyclo-oxygenase (COX) enzymes and reduce prostaglandin formation, but long-term use can irritate the stomach or affect kidneys, so they must be used carefully.NCBI+1Muscle relaxants (e.g., baclofen, tizanidine)
If a person with CMT2S has spasticity or painful muscle spasms, muscle relaxants may be used. They act on the spinal cord or brainstem to calm overactive reflexes. The purpose is to reduce stiffness and cramps, especially at night. Side effects include drowsiness and weakness, so dosing must be low and closely monitored.NCBI+1Analgesics including cautious opioid use
Paracetamol (acetaminophen) is often used for mild pain. In severe cases where other medicines fail, doctors may use short-term opioids, but this is usually avoided because of risks of dependence and side effects such as constipation and drowsiness. In CMT2S, emphasis is usually on non-opioid options and non-pharmacological tools first.NCBI+1Mood and anxiety medications
Living with chronic disability may lead to depression or anxiety. Selective serotonin reuptake inhibitors (SSRIs) or SNRIs can help. Their mechanism is to balance chemicals in brain circuits that regulate mood, sleep, and energy. In CMT2S, these medicines aim to improve quality of life so that people can participate better in therapy.NCBI+1Investigational antisense oligonucleotide VCA-894A (research only)
For CMT2S specifically, an antisense oligonucleotide drug called VCA-894A is being developed. The FDA has approved it as an investigational new drug (IND) for clinical trials, not as a general treatment yet. VCA-894A is a short piece of modified genetic material designed to bind a cryptic splice site in the IGHMBP2 gene and correct faulty splicing. The purpose is to restore more normal IGHMBP2 protein levels and improve nerve function in people with a specific mutation. At present, it is only available in research settings, and dosing and safety are carefully studied in trials.PMC+3Charcot-Marie-Tooth Association+3NeurologyLive+3
(Other drugs that may sometimes be used in CMT, such as different anticonvulsants or antidepressants, follow similar principles: they target pain or mood, not the genetic cause.)
Dietary molecular supplements
Supplements cannot cure autosomal recessive axonal CMT2S, but some may support nerve and muscle health. Any supplement should be discussed with a doctor to avoid interactions.
Vitamin B12 – Supports myelin and red blood cell production. Deficiency can worsen neuropathy. Typical practice uses medically supervised doses; too much can also cause problems in some people.
Vitamin B1 (thiamine) and B6 (pyridoxine) in safe doses – These vitamins help nerve cells use energy and transmit signals. Very high B6 doses over time can actually cause neuropathy, so dosing must follow medical guidance.
Alpha-lipoic acid – An antioxidant used in some diabetic neuropathy studies. It may help reduce oxidative stress in nerves and improve pain, but evidence in CMT2S is limited. It works by recycling other antioxidants and improving mitochondrial function.
Coenzyme Q10 – Important in mitochondrial energy production. Some small studies in other neuromuscular disorders suggest possible benefit in fatigue and muscle performance by improving ATP generation in cells.
Omega-3 fatty acids (fish oil) – These fats may have anti-inflammatory effects and support cell membranes, including nerve cell membranes. They might help overall cardiovascular and nerve health, but results are modest and not specific to CMT2S.
Vitamin D – Supports bones and muscle function. People with limited mobility often have low vitamin D. Correcting deficiency helps reduce fracture risk and may improve muscle strength.
Vitamin E – A fat-soluble antioxidant that protects cell membranes from oxidative damage. Severe vitamin E deficiency can cause neuropathy; balanced replacement can help if levels are low.
Acetyl-L-carnitine – Involved in fatty acid transport into mitochondria. Some neuropathy studies suggest it may support nerve regeneration and reduce pain, possibly by improving energy metabolism in neurons.
Magnesium – Important for nerve conduction and muscle relaxation. Correcting deficiency may reduce cramps and improve sleep quality, but high doses can cause diarrhea or heart rhythm problems.
Curcumin (turmeric extract) – Has anti-inflammatory and antioxidant properties. In theory it may reduce inflammation around nerves and muscles, but strong evidence in CMT is lacking. It is often used as part of an overall anti-inflammatory diet rather than a stand-alone “treatment.”
(For all supplements, the key message is: use only under specialist advice, at safe doses, and as support, not as a replacement for medical care.)
Immune-booster, regenerative and stem-cell–related approaches
For CMT2S, there are no approved immune-booster or stem cell drugs that reverse the disease. However, researchers are exploring several ideas:
Gene-targeted antisense therapy (like VCA-894A) – This is a precision genetic approach, not a classic “immune booster.” It works by correcting how the IGHMBP2 gene is read, aiming to restore more normal protein levels in motor neurons.Charcot-Marie-Tooth Association+2PMC+2
AAV-based gene replacement therapy (preclinical) – Animal models of IGHMBP2-related disease are being studied with adeno-associated virus vectors carrying a healthy copy of the gene. The aim is to deliver the correct gene into motor neurons to rescue their function.
Neural stem cell transplantation (experimental) – In theory, transplanting neural stem cells or progenitor cells might support or replace damaged neurons. Mechanisms include releasing growth factors, modulating inflammation, and possibly integrating into circuits, but this is still experimental and not available as routine treatment.NMD Journal+1
Mesenchymal stem cell therapy for neuropathy (research) – Mesenchymal stem cells from bone marrow or fat may release protective cytokines and growth factors that support nerve repair and reduce inflammation. Studies in other neuropathies are ongoing, but there is no established protocol for CMT2S.
Neurotrophic factor-based therapies – Compounds that mimic or boost natural nerve growth factors (like NGF, BDNF, GDNF) are being investigated to support axon survival. The mechanism is to activate receptors on neurons that promote survival and axonal regeneration.ScienceDirect+1
Mitochondria-targeted antioxidant or metabolic therapies – Because axonal degeneration often involves mitochondrial stress, some research focuses on drugs that stabilize mitochondria, reduce oxidative damage, or boost energy production. These are still in the research phase and not specific to CMT2S yet.
All these approaches are experimental and should only be accessed through properly approved clinical trials.
Surgical options (procedures and why they are done)
Surgery does not fix the genetic cause of CMT2S, but it can correct deformities and improve function in selected people.nhs.uk+2Cleveland Clinic+2
Foot deformity correction (osteotomy and soft-tissue procedures)
Over time, muscle imbalance can cause high arches (pes cavus), claw toes and unstable ankles. Foot and ankle surgeons may cut and realign bones (osteotomies) and lengthen or release tight tendons. The purpose is to create a more plantigrade (flat) foot so walking is more stable and pain is reduced.Tendon transfer surgery
In this procedure, a tendon from a stronger muscle is moved to replace the function of a weak muscle, such as one that lifts the foot. This can help correct foot drop and improve gait. The aim is to rebalance forces around the ankle so braces may be lighter or sometimes no longer needed.Joint fusion (arthrodesis) in severe deformity
When joints are severely deformed or unstable and cause pain, fusion surgery can permanently join bones so the joint no longer moves. The purpose is stability and pain relief, accepting some loss of flexibility in exchange for safer standing and walking.Spinal surgery for scoliosis
If CMT-related muscle weakness leads to significant spinal curvature that affects posture or breathing, spine surgeons may correct and fuse parts of the spine. The purpose is to protect lung function and reduce pain or progression of the curve.Nerve decompression (e.g., carpal tunnel release)
Some people with CMT2S may also develop entrapment neuropathies like carpal tunnel syndrome. Releasing the compressed nerve surgically can reduce numbness and pain and protect remaining nerve function. The mechanism is purely mechanical: removing tight tissue around the nerve so blood flow and conduction improve.
Prevention and lifestyle risk reduction
CMT2S itself cannot be “prevented” because it is genetic, but many complications can be reduced:
Genetic counselling before pregnancy – Helps carrier couples understand recurrence risk and options such as prenatal or preimplantation genetic diagnosis.
Early diagnosis and early therapy – Starting physiotherapy, orthotics and foot care early can delay deformities and maintain mobility longer.NCBI+1
Avoiding neurotoxic drugs and toxins – Inform all healthcare providers about CMT so they avoid medicines known to harm peripheral nerves when possible.
Routine foot checks and skin care – Looking daily for blisters, redness or wounds and getting podiatry care prevents ulcers and infections.ScienceDirect+1
Fall-proofing home and school/work – Removing trip hazards, using good lighting, and installing grab bars where needed reduces fractures and head injuries.Charcot-Marie-Tooth Disease+1
Maintaining a healthy weight – Less weight on weak legs lowers joint stress and strain on muscles.
Regular low-impact exercise – Keeps joints flexible and supports cardiovascular health without over-loading weak muscles.
Not smoking and limiting alcohol – Smoking and heavy alcohol use can worsen circulation and nerve damage.
Good control of other diseases (like diabetes) – If present, controlling blood sugar and blood pressure stops extra nerve damage from other causes.
Vaccination and infection prevention – Vaccines and prompt treatment of infections lower the risk of severe illness in people whose mobility or breathing is already limited.
When to see a doctor
Someone with suspected or known autosomal recessive axonal CMT2S should see a doctor or specialist if:
They notice new or rapidly worsening weakness, especially in their legs or hands.
They start to fall often or feel unsafe walking, even with braces.
They develop new severe nerve pain, burning or electric shock feelings that disturb sleep.
They notice foot wounds, color changes, swelling or infections that do not heal.
They have new breathing problems, snoring with pauses, morning headaches or unexplained daytime sleepiness.ijbm.org+2Cleveland Clinic+2
They develop obvious spinal curvature, back pain, or difficulty sitting upright.
Their mood becomes very low, anxious or hopeless, or they lose interest in usual activities.
A family member wants counselling about carrier status or future pregnancies.
Urgent medical care is needed for sudden breathing difficulty, chest pain, high fever with leg ulcers or rapidly progressive weakness.
What to eat and what to avoid
What to eat
A balanced diet with whole grains, fruits, and vegetables to give vitamins, minerals and fiber.
Lean protein such as fish, poultry, beans and lentils to support muscle repair.
Healthy fats from nuts, seeds, olive oil and fish to support cell membranes and heart health.
Calcium-rich foods (dairy or fortified alternatives) and vitamin-D-rich foods to support bones and muscles.
Plenty of fluids (mostly water) to avoid dehydration, which can worsen fatigue and cramps.
What to avoid or limit
Very sugary drinks and snacks that add empty calories and promote weight gain.
Highly processed fast foods high in saturated fat and salt, which strain the heart and circulation.
Excessive caffeine, which can worsen sleep and anxiety in some people.
Heavy alcohol use, which can damage nerves further and interact with medicines.
Extreme “fad” diets that severely restrict calories or major food groups without medical supervision.
A dietitian who understands neuromuscular disease can personalize nutrition to support weight control, bone health and overall wellbeing.NCBI+1
Frequently asked questions (FAQs)
Is CMT2S the same as other types of Charcot-Marie-Tooth disease?
No. CMT2S is a specific axonal, autosomal recessive subtype linked mainly to IGHMBP2 mutations. Other CMT types can be demyelinating (CMT1), X-linked, or caused by different genes. Symptoms overlap, but the genetic cause and inheritance pattern differ.NCBI+2Muscular Dystrophy Association+2Can CMT2S be cured right now?
No cure is currently available. Treatment focuses on rehabilitation, braces, surgery for deformities, and pain and mood management. Experimental gene-targeted therapies like VCA-894A are still in clinical trials.PMC+3NCBI+3ScienceDirect+3Does everyone with CMT2S end up in a wheelchair?
Not everyone. Disease severity varies. Some people remain able to walk with braces for many years, while others may need wheelchairs for longer distances. Early therapy and orthotics help maintain mobility as long as possible.Orpha+2Cleveland Clinic+2Can exercise make CMT2S worse?
Too-intense, high-impact exercise can cause overuse injuries and fatigue, but properly designed, low-impact exercise is helpful. Physiotherapists plan safe programs that protect weak muscles while keeping joints flexible and maintaining cardiovascular health.Physiopedia+2nhs.uk+2Is CMT2S always inherited from both parents?
Yes, in autosomal recessive CMT2S a person usually inherits one faulty IGHMBP2 gene from each parent. Parents are typically carriers without symptoms. Rarely, new mutations may occur, but most cases follow recessive inheritance.NCBI+2Muscular Dystrophy Association+2Can CMT2S affect breathing?
In some IGHMBP2-related disorders, including CMT2S, respiratory muscles can be affected. People may experience reduced lung capacity or sleep-related breathing problems. Regular monitoring and early respiratory support can help.ijbm.org+1Does CMT2S affect thinking or memory?
CMT2S mainly affects peripheral nerves, not the brain itself, so thinking and memory are usually normal. However, chronic pain and fatigue can make concentration harder, so managing symptoms is important.NCBI+1Is pregnancy safe for someone with CMT2S?
Many people with CMT can have safe pregnancies with good medical support. However, extra weight, balance changes and delivery planning should be discussed with neurologists and obstetricians. Genetic counselling is important for family planning.NCBI+1Can children with CMT2S participate in sports?
Yes, but activities should be low-impact and safe, like swimming or cycling. High-impact sports with a high risk of ankle injuries or falls should be approached cautiously. A physiotherapist can guide what is safe for each child.Physiopedia+2orthobullets.com+2Will braces or orthotics weaken my muscles?
Correctly chosen braces (like AFOs) are designed to support weak muscles and protect joints, not to weaken them. They actually reduce fatigue and allow safer, more natural walking, especially when combined with exercise.Charcot-Marie-Tooth Association+1Are there special shoes for CMT2S?
Yes. Custom shoes or inserts can support high arches, narrow heels and prevent pressure points. Orthotists and podiatrists work together to design footwear that improves walking and comfort.Mayo Clinic+2Charcot-Marie-Tooth Association+2Can diet alone treat CMT2S?
No. Diet cannot repair the genetic fault or fully stop nerve damage. However, a healthy diet supports muscles, bones and overall health, and helps keep body weight in a range that is easier for weak legs to carry.Are stem cell clinics on the internet safe for CMT2S?
Most commercial “stem cell” clinics advertising cures for neuropathy are not supported by strong scientific evidence and may be risky or unethical. True stem cell or gene therapies should only be taken inside approved clinical trials at recognized centers.NMD Journal+1Can CMT2S get confused with other diseases?
Yes. Other neuropathies, spinal muscular atrophy and metabolic or inflammatory nerve diseases can look similar. Detailed history, examination, nerve conduction studies and genetic testing are needed to confirm CMT2S.NCBI+2American Academy of Neurology+2Where can families find reliable information and support?
Trusted sources include national neuromuscular organizations, CMT foundations, and websites run by large hospitals and national health services. These groups provide education, support groups and updates about research and clinical trials.CMT Research Foundation+2Cleveland Clinic+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
